News | October 17, 2025
Healthium partners with US-based Tisgenx to bring cardiac innovations to India
This partnership marks a significant step in strengthening Healthium’s position in the cardiac care segment
This partnership marks a significant step in strengthening Healthium’s position in the cardiac care segment
Lutavit A/D3 1000/200 NXT provides a combination of vitamin A and vitamin D3 in one formulation
First research project, supported by the Gates Foundation, focuses on developing non-hormonal contraceptives for women in low- and middle-income countries
UZEDY (risperidone) extended-release injectable suspension for subcutaneous use is indicated for use every one or two months for the treatment of schizophrenia in adults
PeptiGlow features premium-grade hydrolyzed collagen peptides that support skin elasticity and hydration
First patients enrolled in Phase I trial with KQB548, an investigational KRAS inhibitor designed to treat KRAS G12D-mutated tumors
Conventional plasmids as a pharmaceutical material are not only suboptimal in safety and function, but exceedingly costly to produce, prohibitively
States exhorted to ensure rational use of cough syrups, particularly among children, as most coughs are self-limiting and do not require pharmacological treatment
Pioneering innovation aims to transform anticoagulant therapy and improve patient outcomes
Through the new DTP platform, Novartis will make Cosentyx available to patients at a price that reflects the average savings typically retained by insurers and pharmacy benefit managers
Subscribe To Our Newsletter & Stay Updated
